Seroprevalence of hepatitis B and C viruses in moderate and severe COVID-19 inpatients: A cross-sectional study at a referral center in Mexico
Open Access
- 12 February 2022
- journal article
- research article
- Published by Elsevier in Annals of Hepatology
- Vol. 27 (3) , 100684
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry studyJournal of Hepatology, 2021
- A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico—A systematic review and meta-analysis (2008–2019)Annals of Hepatology, 2021
- A Stepwise Approach to a National Hepatitis C Screening Strategy in Malaysia to Meet the WHO 2030 Targets: Proposed Strategy, Coverage, and CostsValue in Health Regional Issues, 2019
- Hepatitis B seroprevalence in 10-25-year-olds in Mexico - the 2012 national health and nutrition survey (ENSANUT) resultsHuman Vaccines & Immunotherapeutics, 2018
- Hepatitis C point-of-care diagnostics: in search of a single visit diagnosisExpert Review of Molecular Diagnostics, 2017
- Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypesWorld Journal of Gastroenterology, 2016
- Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013The Lancet, 2015
- Hepatitis B virus burden in developing countriesWorld Journal of Gastroenterology, 2015
- A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: a systematic reviewHepatology International, 2008
- Prevalencia en México de la infección y el estado de portador de la hepatitis B en adultosSalud Pública de México, 2007